Thomas Knittel

InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden.

HepaRegeniX GmbH engages in the development of treatment for acute and chronic liver diseases. It focuses on Mitogen-Activated Protein Kinase 4, which unlocks the regenerative capacity of hepatocytes even in severely diseased livers. The company was founded in by Wolfgang Albrecht in 2017 and is headquartered in Tuebingen, Germany.

Harlan Laboratories, Inc. provided essential, pre-clinical and non-clinical contract research, research models, lab animal diets and services. The firm's focused on providing customers with products and services to optimize the discovery and safety of new medicines and compounds. The company was founded in 1931 and was headquartered in Indianapolis, IN.

Novo Nordisk Pharma GmbH manufacturers and distributes pharmaceutical products. It offers pharmaceutical products for diabetes, menopause, growth hormones and blood clotting which treats chronic diseases: hemophilia, growth disorders and obesity. The company was founded in 1991 and is headquartered in Mainz, Germany.

DeveloGen AG is a biopharmaceutical company engaged in the discovery and development of novel therapeutics for the treatment of metabolic and endocrine disorders with a particular focus on diabetes. DeveloGen develops highly innovative approaches for the treatment of diabetes and obesity targeting key pathophysiological mechanisms such as insulin resistance and loss of insulin-producing beta cells. DeveloGen's product pipeline includes two programs at advanced stages of lead optimization, a small molecule inhibitor program based on a novel and proprietary target to address insulin resistance (type 2 diabetes). A growth factor targeting beta cell regeneration (type 1 and type 2 diabetes). DeveloGen is based in Goettingen, Germany.